6.5 C
New York
Sunday, January 23, 2022

Pfizer COVID-19 vaccine linked to 26-year-old man’s death

Must Read

This diet may help repair damage from traumatic brain injury

There are currently no treatment options for those who have suffered such injuries, though the ketogenic diet...

Who is more exposed to Arthritis? Early warning signs you should know

According to the US CDC, an alarming number of Americans suffer from arthritis, a severe inflammation of the...

A superfruit that helps you boost eyesight as you age

The more you eat this fruit, the better your chances of avoiding early-stage AMD. It's also beneficial...
Kamal Saini
Kamal S. has been Journalist and Writer for Business, Hardware and Gadgets at Revyuh.com since 2018. He deals with B2b, Funding, Blockchain, Law, IT security, privacy, surveillance, digital self-defense and network policy. As part of his studies of political science, sociology and law, he researched the impact of technology on human coexistence. Email: kamal (at) revyuh (dot) com

Authorities in New Zealand announced on Monday that a 26-year-old man died after contracting myocarditis, a rare inflammation of the heart muscle, after receiving his first dosage of the Pfizer COVID-19 vaccine.

In August, health officials revealed that a lady had died after taking her vaccine shot, making this the second death in New Zealand to be connected to a well-known but rare side effect of the vaccine.

“With the current available information, the board has considered that the myocarditis was probably due to vaccination in this individual,” said New Zealand Monitoring Board said in a statement.

The individual had not sought medical advice or treatment for his symptoms before dying just two weeks after taking his first dose. Myocarditis is an inflammation of the heart muscle that can impair the organ’s ability to pump blood and cause irregular heartbeats.

A Pfizer spokesperson said the company was aware of the report of the death in New Zealand, it monitored all reports of possible adverse events, and continued to believe the benefit-risk profile for its vaccine was positive.

A Pfizer spokesman stated that the firm was aware of the New Zealand death report, that it was monitoring all reports of suspected adverse effects, and continued to believe the benefit-risk profile for its vaccine was positive.

Additionally, New Zealand’s vaccine safety board reported that two additional people, including a 13-year-old, died of suspected myocarditis following inoculation. More information was needed before tying the child’s death to the vaccine, and the death of a man in his 60s was unlikely to be related to the vaccine, according to the report.

While the vaccine safety board acknowledged that there were some rare side effects, it concluded that the benefits of vaccination outweighed the risks.

Image Credit: Getty

You were reading: Pfizer COVID-19 vaccine linked to 26-year-old man’s death

- Advertisement -
- Advertisement -

Latest News

- Advertisement -

More Articles Like This

- Advertisement -